In low-grade glioma (LGG), ovarian cancer (OV), and sarcoma (SARC), the impact of IFN-γ expression on patient prognosis is not significantly significant (Fig. 8D–F ).
1
—
—
In low-grade glioma (LGG), ovarian cancer (OV), and sarcoma (SARC), the impact of IFN-γ expression on patient prognosis is not significantly significant (Fig. 8D–F ).